Fresenius Medical Care

Fresenius Medical Care is the world’s leading provider of products and services for people with chronic kidney failure. About 3.9 million patients with this disease worldwide regularly undergo dialysis treatment. Dialysis is a vital blood cleansing procedure that substitutes the function of the kidney in case of kidney failure.

Through its network of about 4,100 dialysis clinics in North America, Europe, Latin America, Asia-Pacific and Africa, Fresenius Medical Care provides dialysis treatments for about 344,000 patients around the globe. Fresenius Medical Care is also the world‘s leading provider of dialysis products such as hemodialysis machines, dialyzers and related disposable products.

The company's strategy is geared toward sustainable growth. Fresenius Medical Care aims to continuously improve the quality of life of patients with kidney disease by offering innovative products and treatment concepts of the highest quality.

Fresenius Medical Care’s corporate headquarters are in Bad Homburg v.d.H., Germany. The headquarters of North America are in Waltham, Massachusetts and the headquarters of Asia-Pacific are located in Hong Kong.

Fresenius Medical Care belongs to Fresenius SE & Co. KGaA healthcare group with a stake of about 32 percent and is one of the two Investment Companies of Fresenius. For this purpose, Fresenius SE & Co. KGaA plans to deconsolidate Fresenius Medical Care AG & Co. KGaA in the course of the change of the legal form into a Aktiengesellschaft (German stock corporation).